about
Safety of Nanoparticles in MedicineEfficient drug delivery of Paclitaxel glycoside: a novel solubility gradient encapsulation into liposomes coupled with immunoliposomes preparationTopical delivery of aceclofenac: challenges and promises of novel drug delivery systems.The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.Efficacy of combined therapy with paclitaxel and low-level ultrasound in human chronic myelogenous leukemia cell line K562.Shape-controlled paclitaxel nanoparticles with multiple morphologies: rod-shaped, worm-like, spherical, and fingerprint-like.Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug deliveryTherapeutic efficacy of paclitaxel and carboplatin via arterial or venous perfusion in rabbits with VX-2 tongue cancer.Design considerations for nanotherapeutics in oncology.Taxane anticancer agents: a patent perspective.Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatmentShrinkage of pegylated and non-pegylated liposomes in serumNanoparticles containing insoluble drug for cancer therapy.Liposomal chemotherapeutics.What nanomedicine in the clinic right now really forms nanoparticles?Liposomal forms of anticancer agents beyond anthracyclines: present and future perspectives.Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.Use of nanotechnology for improved pharmacokinetics and activity of immunogenic cell death inducers used in cancer chemotherapy.Evaluation of glycosylated docetaxel-encapsulated liposomes prepared by remote loading under solubility gradient.Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.A7RC peptide modified paclitaxel liposomes dually target breast cancer.Liposomal formulation for co-delivery of paclitaxel and lapatinib, preparation, characterization and optimization.Development and validation of a reversed-phase HPLC method for the quantification of paclitaxel in different PLGA nanocarriers.MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivoTrends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulationMeta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents.Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive AgentsPractical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency.Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies.Evolution and Clinical Translation of Drug Delivery Nanomaterials.Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.Cytotoxic, Apoptotic and Genotoxic Effects of Lipid-Based and Polymeric Nano Micelles, an In Vitro Evaluation.Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells.
P2860
Q28083076-340B2B87-351F-4936-A2DA-71AC244B90F2Q28543361-E47F05DC-23FE-4B7E-B716-45293AFB0C96Q33862052-5AA91090-07DD-4C10-AD33-1FE51F765552Q33925422-15EB4889-AEEC-4081-B10E-95F6109D8262Q34502573-C8ED39CB-F289-4FC2-9200-8D37ED5777BEQ34555547-E99FB2E2-61E0-4A62-805E-BEA09BCA179CQ34953043-DDBE2B4B-B730-4477-AAFB-E1AA289B407AQ35100764-23B1BA75-FB93-47F2-B65D-9BC4BCBF62D8Q35168687-504C329C-0B4C-46D1-816D-F058DDB882E3Q35791394-F671F75C-5882-4289-B87F-191C539D4B10Q36236848-28E6BD65-2147-4C9B-B59B-8F9E0A0281B4Q37087888-5DEFCD78-A9DB-45F0-804C-A7DCA3C25952Q37119643-307AB1E6-D97C-47A6-94A0-62108A5895C8Q37408773-E67C7FDD-9723-4380-B779-0AAB31BC3871Q37449547-77F9AF75-9B8A-4A5E-84E9-1740BEB06FBCQ37693046-1B12B96C-3DFA-479A-8886-52828B95A1D3Q38167883-F403D0B7-8654-48BE-9F2E-16779BC55714Q38177770-0753927C-D59E-437A-BD45-AC3282468F6FQ38242272-D8F50A01-E5E5-483F-96F3-613408DC82F4Q38588547-2CBC071C-8C31-45D9-B3B7-CDA967ABFD91Q38789551-17657BDA-FE1B-466E-849E-A2DECE2B2192Q38793511-6AD5FAF1-27F8-4FF5-B91D-1C5D8358ABE4Q38822833-78AAD442-F074-4293-B757-CE504187171FQ38842323-7265D995-2E41-4768-93F3-18C5BC55AFA2Q38844243-2AC295AA-EC59-4363-B510-0D5C02D3A6BAQ38859668-47C5D550-77C3-40EF-A2CA-68D581649E06Q38869805-93536CF2-3620-4CD3-8C5A-671D1C60B9A7Q38949920-3759A134-E7B8-4B1C-8B5E-3D060FEC4302Q38981743-FD3EA70E-D0C3-42F1-A5FD-5BAD5584B578Q39215897-AFD37FFF-0974-44B2-9974-6F92189E9FC7Q39377012-FF45E0C1-EE44-486B-B8C7-EC8EE21EBE67Q41421955-09F7EF06-9FD0-4838-B0CC-C7F7663E732AQ41953738-2EB9AC83-0792-4E82-9483-98F150A8E3F9Q42755952-D1319674-FFFD-4A67-BF43-854EBEC00001Q45338727-8F1D25CE-7CC5-46D3-9EB6-F8205A3F48CEQ45932069-B3AD064F-1A35-402A-A57C-A2657011AD24Q47263594-AAF4CEBD-5A16-4387-8B8C-D81D9E1192BBQ47965422-2E117E8F-A530-4470-9AAA-E3B0C3598B20Q48309189-AED8EC43-6D68-49D7-BF90-955635A8C44DQ48433803-1B6C9B32-D262-47C2-BCAC-649628A5904B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Liposomal paclitaxel formulations.
@en
type
label
Liposomal paclitaxel formulations.
@en
prefLabel
Liposomal paclitaxel formulations.
@en
P1476
Liposomal paclitaxel formulations.
@en
P2093
Jaroslav Turánek
Stěpán Koudelka
P304
P356
10.1016/J.JCONREL.2012.09.006
P407
P577
2012-09-15T00:00:00Z